Imat 400mg Imatinib Tablet

Imat 400mg Imatinib Tablet is a prescription targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GISTs), and certain other cancers. It contains Imatinib, a tyrosine kinase inhibitor (TKI) that works by blocking abnormal proteins responsible for the growth and multiplication of cancer cells. By targeting these specific pathways, Imat 400mg Imatinib Tablet helps slow disease progression and supports effective long-term cancer management. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to assess treatment effectiveness and manage potential side effects. Patients should use Imat 400mg Imatinib Tablet only as prescribed by their healthcare provider and attend all recommended follow-up appointments during treatment.